IPO ROUND-UP: Public appetite for medtech stocks on the up
This article was originally published in Clinica
Executive Summary
With June proving to be a bumper month for completed IPOs, the first half of 2015 looks well on its way to outperform 2014 when it comes to stock float successes.
You may also be interested in...
Q2 Breathes A Little Life Into Medtech IPO Scene
After a lackluster first quarter, the medtech IPO scene is gradually livening up with several companies their shares successfully floated on the public markets for the first time in the second quarter. But activity levels are still a far cry from the bonanza of 2015.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.